BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 13270267)

  • 1. Studies on the management of mouse leukemia (L1210) with antagonists of folic acid.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N
    Cancer Res; 1955 Dec; 15(11):742-7. PubMed ID: 13270267
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined treatment of advanced leukemia (L1210) in mice with amethopterin and 6-mercaptopurine.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Nov; 17(5):631-8. PubMed ID: 13377178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation on the effect of folic acid antagonist 4-aminopteroyl-aminoadipic acid on the development of transplanted leukosis in mice].
    KIRSANOVA VA; VODOLAZSKAIA NA
    Vopr Onkol; 1955; 1(4):59-64. PubMed ID: 13299820
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity of mice surviving systemic leukaemia (L1210) to antifolic resistant variants of the disease.
    GOLDIN A; HUMPHREYS SR; CHAPMAN GO; CHIRIGOS MA; VENDITTI JM
    Nature; 1960 Jan; 185():219-21. PubMed ID: 13850658
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of tumor variants recovered from mice with systemic leukemia (L1210) after extensive therapy with 3',5'-dichloroamethopterin and 3'-bromo-5'-chloroamethopterin.
    HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1959 Oct; 23():633-53. PubMed ID: 14405382
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.
    VENDITTI JM; SCHRECKER AW; MEAD JA; KLINE I; GOLDIN A
    Cancer Res; 1960 Nov; 20():1451-6. PubMed ID: 13780697
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.
    GOLDIN A; HUMPHREYS SR; MANTEL N; VENDITTI JM
    J Natl Cancer Inst; 1956 Aug; 17(2):203-12. PubMed ID: 13357939
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of amethopterin resistance in leukemia. I. Effects of weak folic acid antagonists on mouse leukemias.
    BURCHENAL JH; JOHNSTON SF; WARING GB
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):348-51. PubMed ID: 14892015
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatographic studies of purine metabolism. III. Effects of A-methopterin on formate-C14 utilization in mice bearing susceptible and dependent L1210 leukemia.
    TOMISEK AJ; KELLY HJ; REID MR; SKIPPER HE
    Arch Biochem Biophys; 1958 Nov; 78(1):83-94. PubMed ID: 13595905
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of growth of amethopterinsensitive and amethopterin-resistant pairs of lymphocytic neoplasms by dietary folic-acid deficiency in mice.
    POTTER M; BRIGGS GM
    J Natl Cancer Inst; 1962 Feb; 28():341-51. PubMed ID: 14488297
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of A-methopterin on nucleic acid synthesis in leukemia spleen breis.
    BALIS ME; DANCIS J
    Cancer Res; 1955 Oct; 15(9):603-8. PubMed ID: 13261082
    [No Abstract]   [Full Text] [Related]  

  • 12. ACTIVITY CHANGES OF SOME ENZYME SYSTEMS INTERFERING IN FOLIC ACID METABOLISM IN THE COURSE OF MOUSE LEUKAEMIA OF AKR-STRAIN.
    SOUCEK J; MOTYCKA K; SLAVIK K
    Neoplasma; 1964; 11():193-8. PubMed ID: 14163211
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of folic acid antagonists as related to brain and cerebrospinal fluid.
    RALL DP; RIESELBACH RE; OLIVERIO VT; MORSE E
    Cancer Chemother Rep; 1962 Feb; 16():187-90. PubMed ID: 14490033
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolic displacement of folic acid by aminopterin; studies in leukemia patients.
    SWENDSEID ME; SWANSON AL; MILLER S; BETHELL FH
    Blood; 1952 Mar; 7(3):302-6. PubMed ID: 14904512
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity changes of some enzyme systems interferring into the metabolism of folic acid in the livers of mice in the course of LaHVUFB leucaemia.
    SOUCEK J; SOCHMAN J; SLAVIK K
    Neoplasma; 1963; 10():177-82. PubMed ID: 13978369
    [No Abstract]   [Full Text] [Related]  

  • 16. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA; THOMAS LB; HUMPHREYS SR; GLYNN JP; GOLDIN A
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of experimental mouse hemoblastosis. 3. Chemotherapy of the LaH VUFB leukemia with some 4-amino analogues of folic acid.
    Soucek J; Sochman J; Motycka K; Novotná O; Slavík K
    Neoplasma; 1965; 12(4):425-33. PubMed ID: 5854414
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
    FISCHER GA
    Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of A-methopterin on formate-C14 incorporation by mouse leukemias in vitro.
    WILLIAMS AD; SLATER GG; WINZLER RJ
    Cancer Res; 1955 Sep; 15(8):532-6. PubMed ID: 13250519
    [No Abstract]   [Full Text] [Related]  

  • 20. An investigation into the synergistic antileukemic action of amethopterin and 6-mercaptopurine in mice.
    GOLDIN A; VENDITTI JM; HUMPHREYS SR; DENNIS D; MANTEL N; GREENHOUSE SW
    J Natl Cancer Inst; 1955 Aug; 16(1):129-38. PubMed ID: 13243117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.